In addition to encouraging people with HIV to prioritize self-care, Gilead Sciences' “Choose U” campaign name also refers to the “U=U” movement, denoting how maintaining an undetectable viral load ...
Gilead Sciences has announced a collaboration with the US State Department and the President’s Emergency Plan for AIDS Relief (PEPFAR) to distribute its injectable HIV-1 capsid inhibitor, lenacapavir, ...
Since the HIV epidemic began, the diagnosis of HIV has evolved from a death sentence to a chronic, but manageable condition by starting and staying on treatment. HIV treatment can help people live ...
Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication
Before its headline-grabbing 100% efficacy rate in an HIV prevention trial and subsequent long-acting prophylactic approval, Gilead Sciences' lenacapavir was approved in 2022 as Sunlenca for the ...
Advocacy groups called out CVS Health's August decision to not include Yeztugo in its formularies in a Sept. 18 letter. (Photo by Justin Sullivan/Getty Images) The Centers for Disease Control and ...
Dec 15 (Reuters) - Gilead Sciences (GILD.O), opens new tab said on Monday its experimental HIV treatment was found to be statistically non-inferior to its top-selling drug Biktarvy in a late-stage ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced a partnership with the U.S. State Department and the United States President’s Emergency Plan for AIDS Relief ...
– Funding Will Reach Under-Resourced Communities Most Impacted by the HIV Epidemic and COVID-19 Pandemic – FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc., (Nasdaq: GILD) today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results